Changchun University of Chinese Medicine, 1035 Bo Shuo Road, Changchun City, Jilin Province, China.
Department of Hepatology, First Affiliated Hospital to Changchun University of Chinese Medicine, 1478 Gongnong Road, Changchun City, Jilin Province, China.
Medicine (Baltimore). 2021 Oct 29;100(43):e27659. doi: 10.1097/MD.0000000000027659.
Primary liver cancer (PLC) is one of the most common malignant tumors in the world, and its incidence and fatality rate are increasing year by year. Due to the large population base in China, the aging population is severely affected by environmental pollution, eating habits, and unhealthy lifestyles. And many other influences have caused the number of new PLC cases and deaths in China to rank first in the world. Acupuncture combined with external application of Chinese medicine to treat PLC is currently one of the commonly used treatments in China. However, this combined treatment still lacks evidence-based medicine support. Therefore, this systematic review and meta-analysis aims to evaluate the efficacy and safety of acupuncture combined with external application of traditional Chinese medicine in the treatment of PLC.
We will search PubMed, Web of Science, GCBI, Embase, OVID, AMED, Cochrane Library, CNKI, VIP, CBM, and Wanfang databases. As of September 15, 2021, there are no restrictions on search language, publication time, and publication status. We will use the following medical keywords to search, including: "acupuncture", "external application of traditional Chinese medicine", and "primary liver cancer". At the same time, we will manually search all reference lists from relevant systematic reviews to find other eligible studies. We will use the random effects model in REVMAN v5.3 for meta-analysis. The study for acupuncture combined with Chinese herbal medicine in the treatment of PLC was a randomized controlled study. Two researchers will independently review the research selection, data extraction, and research quality assessments. Finally, we will observe the outcome measures.
This study will provide evidence-based guidance for the treatment of PLC with acupuncture and the external application of traditional Chinese medicine and offers new ideas and methods for the treatment of PLC.
原发性肝癌(PLC)是世界上最常见的恶性肿瘤之一,其发病率和死亡率逐年上升。由于中国庞大的人口基数、人口老龄化严重,加上环境污染、饮食习惯和不健康的生活方式等诸多因素的影响,导致中国 PLC 的新发病例和死亡人数均位居世界第一。针灸联合中药外用来治疗 PLC 是目前中国常用的治疗方法之一。但是,这种联合治疗方法仍然缺乏循证医学的支持。因此,本系统评价和荟萃分析旨在评估针灸联合中药外用来治疗 PLC 的疗效和安全性。
我们将检索 PubMed、Web of Science、GCBI、Embase、OVID、AMED、Cochrane 图书馆、CNKI、VIP、CBM 和万方数据库。截至 2021 年 9 月 15 日,对检索语言、出版时间和出版状态没有限制。我们将使用以下医学关键词进行搜索,包括:“针灸”、“中药外治”和“原发性肝癌”。同时,我们将手动搜索所有相关系统评价的参考文献列表,以找到其他合格的研究。我们将使用 REVMAN v5.3 中的随机效应模型进行荟萃分析。针灸联合中药治疗 PLC 的研究为随机对照研究。两名研究人员将独立审查研究选择、数据提取和研究质量评估。最后,我们将观察结局指标。
本研究将为针灸联合中药治疗 PLC 提供循证指导,并为 PLC 的治疗提供新的思路和方法。